01Research Directions

L-Methionine research directions

01Research Directions

Why this compound has a literature

L-methionine occupies an unusual position in amino acid research because it is not only a protein building block but the entry point to the transmethylation and transsulfuration pathways, feeding S-adenosylmethionine and homocysteine. That biochemistry means methionine intake changes measurable metabolic flux, which has made it a variable of interest in one-carbon metabolism research, in rodent lifespan work, and in oncology metabolism. It is also the first limiting amino acid in most plant proteins, which drives the animal-nutrition demand that accounts for the bulk of world production.

02Literature

What the literature investigates

Entry point to one-carbon metabolism

Methionine is the substrate from which S-adenosylmethionine is formed and, after demethylation, becomes homocysteine, which can be remethylated back to methionine using folate and vitamin B12 as cofactors or diverted into transsulfuration. A 2019 review in the Journal of Inherited Metabolic Disease set out the biochemistry, pathways and regulation of the vitamin B12- and folate-dependent methionine remethylation cycle. The practical implication reported across this literature is that methionine status cannot be discussed independently of folate and B12 status, since the same cycle consumes all three. This is a mechanistic and clinical-biochemistry literature; it describes a pathway rather than an outcome from supplementation, and formulators should read it as a reason methionine is often specified alongside B-vitamin cofactors in clinical nutrition matrices rather than as evidence of any effect.

Methionine restriction: a literature about less, not more

Much of the modern experimental methionine literature investigates restriction. A 2013 review summarised rodent studies in which dietary methionine was restricted by around 80%, reporting associated reductions in adipose tissue mass, changes in mitochondrial biogenesis and energy expenditure, and altered lipid and carbohydrate homeostasis; a 2016 review in the Annals of the New York Academy of Sciences surveyed methionine restriction and lifespan control across model organisms. A 2019 Nature paper reported that dietary methionine restriction influenced therapy response in mouse cancer models and altered one-carbon and methionine metabolism in humans, establishing methionine intake as a variable that measurably changes human metabolic flux. This body of work is preclinical or mechanistic and does not evaluate methionine supplements, but it is the main reason methionine is discussed differently from other essential amino acids in contemporary nutrition science.

Acute high-dose tolerability

Methionine has a narrower documented tolerance window than most amino acids, and this has been examined directly because the methionine loading test is a standard clinical procedure. A 2002 study recorded acute complications during standard loading at 100 mg/kg body weight in 296 patients with coronary or peripheral arterial disease and 591 controls, reporting transient complications in 33% of women and 16.5% of men, with dizziness the most common symptom, alongside sleepiness, nausea, polyuria and blood pressure changes; no deaths occurred within 30 days and the authors concluded the test could be considered safe. A dedicated 2006 review of methionine toxicity in humans examined this question specifically, and a broader 2022 review of amino acid supplement side effects discussed methionine among other amino acids. Buyers should note that this is one of the amino acids where dose framing genuinely matters.

Stereochemistry and source form

Methionine is one of the few amino acids where the racemic DL- form is a mainstream commercial product, because the D-enantiomer can be converted to L-methionine in vivo. Whether the two are nutritionally equivalent has been tested most systematically in poultry. A 2023 meta-analysis of broiler studies published since 2007 reported that linear regression placed DL-methionine at roughly 95% as efficacious as L-methionine for average daily gain and feed conversion, while a fitted non-linear exponential model placed the figures at 91.3% and 76.6% respectively, with the feed conversion estimate not reaching conventional significance. A 2024 broiler bioavailability study addressed the same question. The relevant point for a purchaser is that the two forms are not automatically interchangeable at equal weight in the published animal data, and that this comparison has essentially only been made in poultry.

03Specification

What this means when you specify the material

Three things follow from this literature for spec-setting. First, the human dosing precedent that exists is largely from the methionine loading test at 100 mg/kg as a single acute dose in a clinical setting, not a supplement pattern, so it is not a serving-size reference. Second, DL- and L-methionine were not equivalent at equal weight in the poultry meta-analysis, so the enantiomeric form must be stated explicitly on the specification and not treated as a commercial detail. Third, methionine's chemistry ties it to folate and B12 status, which is why clinical-nutrition customers often ask about the cofactor matrix rather than methionine alone.

04References

Cited literature

Research context only. Each entry describes what a published study examined and reported. These are not claims about this raw material, and not claims about any finished product. Regulatory and labelling judgements belong to the brand placing the product on its market.

A review set out the biochemistry, pathways and regulation of the vitamin B12- and folate-dependent methionine remethylation cycle, describing how methionine, S-adenosylmethionine and homocysteine interconvert. Froese DS, Fowler B, Baumgartner MR. J Inherit Metab Dis. 2019;42(4):673-685. PMID 30693532 DOI 10.1002/jimd.12009
A review summarised rodent studies in which dietary methionine was restricted by approximately 80%, reporting associated reductions in adipose tissue mass, increased mitochondrial biogenesis and energy expenditure, and changes in lipid and carbohydrate homeostasis. Perrone CE, Malloy VL, Orentreich DS, Orentreich N. Exp Gerontol. 2013;48(7):654-60. PMID 22819757 DOI 10.1016/j.exger.2012.07.005
A review surveyed the literature on methionine restriction and lifespan control across model organisms. Lee BC, Kaya A, Gladyshev VN. Ann N Y Acad Sci. 2016;1363:116-24. PMID 26663138 DOI 10.1111/nyas.12973
A study reported that dietary methionine restriction influenced therapy response in mouse cancer models and altered one-carbon and methionine metabolism in humans, establishing methionine intake as a variable that measurably changes human metabolic flux. Gao X, Sanderson SM, Dai Z, et al. Nature. 2019;572(7769):397-401. PMID 31367041 DOI 10.1038/s41586-019-1437-3
In an epidemiological study of 296 patients with arterial disease and 591 controls undergoing a standard 100 mg/kg methionine loading test, transient complications were recorded in 33% of women and 16.5% of men, dizziness being the most common; no deaths occurred within 30 days and the authors concluded the test may be considered a safe procedure. Krupková-Meixnerová L, Veselá K, Vitová A, Janosíková B, Andel M, Kozich V. Clin Nutr. 2002;21(2):151-6. PMID 12056788 DOI 10.1054/clnu.2001.0523
A dedicated review examined the toxicity of methionine in humans. Garlick PJ. J Nutr. 2006;136(6 Suppl):1722S-1725S. PMID 16702346 DOI 10.1093/jn/136.6.1722S
A meta-analysis of broiler studies published since 2007 reported that linear regression placed DL-methionine at 94.97% (average daily gain) and 95.63% (feed conversion ratio) as efficacious as L-methionine, while a non-linear exponential model gave 91.33% and 76.57% respectively, the latter not reaching conventional significance. Asasi R, Ahmadi H, Torshizi MAK, Torshizi RV, Shariatmadari F. Poult Sci. 2023;102(12):103143. PMID 37844530 DOI 10.1016/j.psj.2023.103143
A review of the side effects of amino acid supplements examined the consequences of increased intake of individual amino acids, including effects on renal and gastrointestinal function, ammonia production and competition for shared membrane carriers. Holeček M. Physiol Res. 2022;71(1):29-45. PMID 35043647 DOI 10.33549/physiolres.934790

Need this grade for your line?

RFQ